search
Back to results

Prehabilitation in Frail Colon Cancer

Primary Purpose

Colon Cancer, Fragility

Status
Unknown status
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Prehabilitation
Sponsored by
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Colon Cancer

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of colon cancer requiring surgery
  • More than 65 years of age;
  • Able to read, write and understand French;
  • Frailty phenotype criteria ≥ 3

Exclusion Criteria:

  • The participants have a physical impairment that would seriously impair physical mobility;
  • the surgery is an emergency;
  • The participants have a neuropsychiatric disease.

Sites / Locations

  • Cliniques universitaires Saint-LucRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Prehabilitation group

Control group

Arm Description

Tele-supervised prehabilitation

Usual care

Outcomes

Primary Outcome Measures

Change in cardiorespiratory fitness
Cardiorespiratory is measured by a 6-minute walk test

Secondary Outcome Measures

Change in muscle strength
Muscle strength is measured by using an isokinetic dynamometer
Change in muscle endurance
Muscle endurance is measured by using the "1-minute sit-to-stand-test" (number of sit-to-stand cycles during 1 minute)
Change in quality of life
Quality of life is measured by using the EQ-5D-3L questionnaire
Change in fatigue
Fatigue is measured by using the Functional Assessment of Cancer Therapy: Fatigue questionnaire
Change in level of physical activity
Level of physical activity is measured by using the International Physical Activity Questionnaire Short Form
Change in executive functions
Executive functions is measured by using the Trail Making test
Change in executive functions
Executive functions is measured by using the Fluency verbal test
Change in weight
Weight (kg) is measured by using a bioelectrical impedance analysis
Change in lean body mass
Lean body mass (kg) is measured by using a bioelectrical impedance analysis
Change in fat body mass
Fat body mass (kg) is measured by using a bioelectrical impedance analysis
Energy expenditure
Energy expenditure is measured by using the Sensewear® Armband
Change in Fasting glucose
Fasting glucose is measured by a blood test
Change in Fasting insulin
Fasting insulin is measured by a blood test
Change in cholesterol
Cholesterol is measured by a blood test
Change in neutrophil/lymphocyte
Neutrophil/lymphocyte is measured by a blood test
Change in C-reactive protein
C-reactive protein is measured by a blood test
Adherence
Percentage of sessions completed

Full Information

First Posted
March 17, 2017
Last Updated
September 17, 2019
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
search

1. Study Identification

Unique Protocol Identification Number
NCT03097224
Brief Title
Prehabilitation in Frail Colon Cancer
Official Title
Prehabilitation Before Surgery in Colorectal Cancer With Improved Fast Track Rehabilitation : Part 2
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Unknown status
Study Start Date
April 4, 2017 (Actual)
Primary Completion Date
April 1, 2020 (Anticipated)
Study Completion Date
July 1, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Objectives To investigate the impact of tele-supervised prehabilitation on functional capacity in frail colon cancer patients undergoing colorectal resection and to evaluate the effects of prehabilitation on muscle strength and endurance, quality of life (QoL), executive functions, fatigue and inflammatory and metabolic parameters. Methods A randomized controlled trial will be conducted. Patients will be randomised into either a prehabilitation group (PREHAB) or a control group. Prehabilitation group will participate in a 4-week telerehabilitation before surgery while the control group will receive usual care and World Health Organization recommendations on physical activity for health before surgery. Program exercise will consist of three moderate-intensity aerobic and resistance sessions per week. Subjects will have assessments at baseline, pre-intervention and 8 weeks after surgery. The primary outcome will be functional capacity measured by using the 6-min walk test. The secondary outcomes will be: physical measurements, QoL, level of physical activity, executive functions, fatigue, body composition, blood test, energy expenditure.
Detailed Description
Objectives Primary objective: To assess if a 4-week tele-supervised prehabilitation is effective in improving post-operative cardio-respiratory fitness in frail colon cancer patients. Secondary objectives : To examine if a 4-week preoperative tele-supervised prehabilitation has beneficial effects on muscle strength and endurance, on quality of life, on executive functions, on fatigue, on inflammatory parameters and on metabolic disruption pre-surgery. Background In Belgium, colon cancer is the third most common cancer in men and the second most common in women and is the second cause of cancer death. Surgery is currently the primary treatment for stage I to III. Studies have shown that patients with poor preoperative physical fitness are less able to cope with the adverse effects of surgery and hospitalization resulting in increased risk of mortality, postoperative complications and functional recovery time. Moreover, approximately 60% of colon cancer patients are older than 70 years at diagnosis and more than 50% of older cancer patients have frailty or pre-frailty. Frailty is a state of vulnerability decreased functional reserve, impairment or dysregulation in several physiological systems, and reduced capacity to recover physiological homeostasis after a stress. Nowadays, no frail definition is clearly defined. One widely accepted definition uses the Fried criteria including the assessment of weight loss, physical exhaustion, physical activity level, grip strength and walking speed. Preoperative frail colon cancer patients have a significantly higher risk of adverse postoperative outcomes including institutionalization, length of stay, morbidity and mortality. It seems relevant to intervene during the preoperative period to improve the patient's functional capacity before the surgery, via physical training to overcome the stress of the surgery and to improve postoperative recovery. This process is called "prehabilitation". Structured and supervised programs have shown to be effective and feasible. However, time, resources and expensive care are often a barrier for the patient. Thereby, a home-based tele-supervising rehabilitation would be an attractive therapeutic option to offer a distinct advantage in this regard. To date, no study has studied the effects of tele-supervised prehabilitation in these "frail" patients. Study design A single-blind, randomized, controlled trial will be conducted. Participants will be randomized into either a prehabilitation group or a control group. An assessor who will be blinded to group allocation will collect outcomes measures for each participant. Study sample To be eligible for this study participants will need to meet the following criteria: diagnosis of colon cancer requiring surgery; more than 65 years of age; able to read, write and understand French; Frailty phenotype criteria ≥ 3. Frailty was assessed using the components of the Frailty Phenotype, which was first developed by Fried et al., which consists of five criteria: weight loss, exhaustion, low physical activity, slowness, and weakness. Participants will be excluded if they have a physical impairment that would seriously impair physical mobility; the surgery is an emergency; have a neuropsychiatric disease. Intervention Participants allocated to the prehabilitation group will undertake a telerehabilitation program that will start 4 weeks before the surgery while participants in the control group will receive usual care and World Health Organization recommendations on physical activity for health before surgery. The telerehabilitation program will combine aerobic and resistance training three sessions per week. Each 60-min session will begin and end with a five-minute warm-up/cool. The warm-up will be followed by 25 minutes of aerobic training. Aerobic exercise can include brisk walking, jogging, cycling, or swimming according to patient's preference. The intensity of the exercise was set between 60 à 75% of maximum heart rate (maximal heart rate=220 - age). And between 12 and 16 on Borg's Rating of Perceived Exertion Scale. Each participant will wear a heart monitor. The aerobic training will be followed by resistance exercise performed on eight exercises targeting major muscle groups (abdominal, hamstring, quadriceps, triceps, gluteus maximus, paraspinal muscles and shoulder muscles). Intensity must be between 12 and 16 on the Borg's Rating of Perceived Exertion Scale. A physiotherapist will provide detailed information about the program. The patient will receive a brochure in which there will be descriptions and pictures of exercises and a video including the resistance program was recorded on a website. The researcher will conduct weekly telephone calls with the participants. The aim of these calls will be to solve any problems of carrying out the training sessions and to discuss about possible adverse events. Moreover, the researcher will give messages of support and encouragement to improve adherence to the program. Outcome measures Outcome measures will be assessed at three time points: at baseline (T0), one day before the scheduled date of surgery (T1) and 8 weeks after the surgery (T2). Primary outcome will be cardiorespiratory fitness 6min walk test). Secondary outcomes will be muscle strength and endurance (isokinetic dynamometer and 1-min sit-to-stand-test), quality of life (EQ-5D-3L questionnaire); level of physical activity (International Physical Activity Questionnaire Short Form); fatigue (Functional Assessment of Cancer Therapy: Fatigue); executive functions (Trail Making test and fluency verbal test) ; blood test (neutrophil lymphocyte ratio, C reactive protein, fasting glucose, fasting insulin and cholesterol will be measured by bioelectrical impedance analysis); energy expenditure (Sensewear® armband).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colon Cancer, Fragility

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Prehabilitation group
Arm Type
Experimental
Arm Description
Tele-supervised prehabilitation
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Usual care
Intervention Type
Behavioral
Intervention Name(s)
Prehabilitation
Intervention Description
Four weeks of tele-supervised prehabilitation
Primary Outcome Measure Information:
Title
Change in cardiorespiratory fitness
Description
Cardiorespiratory is measured by a 6-minute walk test
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Secondary Outcome Measure Information:
Title
Change in muscle strength
Description
Muscle strength is measured by using an isokinetic dynamometer
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in muscle endurance
Description
Muscle endurance is measured by using the "1-minute sit-to-stand-test" (number of sit-to-stand cycles during 1 minute)
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in quality of life
Description
Quality of life is measured by using the EQ-5D-3L questionnaire
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in fatigue
Description
Fatigue is measured by using the Functional Assessment of Cancer Therapy: Fatigue questionnaire
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in level of physical activity
Description
Level of physical activity is measured by using the International Physical Activity Questionnaire Short Form
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in executive functions
Description
Executive functions is measured by using the Trail Making test
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in executive functions
Description
Executive functions is measured by using the Fluency verbal test
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in weight
Description
Weight (kg) is measured by using a bioelectrical impedance analysis
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in lean body mass
Description
Lean body mass (kg) is measured by using a bioelectrical impedance analysis
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in fat body mass
Description
Fat body mass (kg) is measured by using a bioelectrical impedance analysis
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Energy expenditure
Description
Energy expenditure is measured by using the Sensewear® Armband
Time Frame
During 7 days before the surgery and during 7 days after the surgery
Title
Change in Fasting glucose
Description
Fasting glucose is measured by a blood test
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in Fasting insulin
Description
Fasting insulin is measured by a blood test
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in cholesterol
Description
Cholesterol is measured by a blood test
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in neutrophil/lymphocyte
Description
Neutrophil/lymphocyte is measured by a blood test
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Change in C-reactive protein
Description
C-reactive protein is measured by a blood test
Time Frame
Assessments at baseline, one day before the surgery and 8 weeks after the surgery
Title
Adherence
Description
Percentage of sessions completed
Time Frame
Weekly through the intervention (during four weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of colon cancer requiring surgery More than 65 years of age; Able to read, write and understand French; Frailty phenotype criteria ≥ 3 Exclusion Criteria: The participants have a physical impairment that would seriously impair physical mobility; the surgery is an emergency; The participants have a neuropsychiatric disease.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gilles Caty, PhD
Phone
+3227641650
Email
gilles.caty@uclouvain.be
First Name & Middle Initial & Last Name or Official Title & Degree
Elise Piraux, PhD student
Phone
+3227645375
Email
elise.piraux@uclouvain.be
Facility Information:
Facility Name
Cliniques universitaires Saint-Luc
City
Brussels
State/Province
Woluwé-Saint-Lambert
ZIP/Postal Code
1200
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gilles Caty
Email
gilles.caty@uclouvain.be
First Name & Middle Initial & Last Name & Degree
Elise Piraux
Email
elise.piraux@uclouvain.be

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
26614304
Citation
Boereboom C, Doleman B, Lund JN, Williams JP. Systematic review of pre-operative exercise in colorectal cancer patients. Tech Coloproctol. 2016 Feb;20(2):81-9. doi: 10.1007/s10151-015-1407-1. Epub 2015 Nov 27.
Results Reference
background
PubMed Identifier
23485231
Citation
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013 Apr;49(6):1374-403. doi: 10.1016/j.ejca.2012.12.027. Epub 2013 Feb 26.
Results Reference
background
PubMed Identifier
19944536
Citation
Pallis AG, Papamichael D, Audisio R, Peeters M, Folprecht G, Lacombe D, Van Cutsem E. EORTC Elderly Task Force experts' opinion for the treatment of colon cancer in older patients. Cancer Treat Rev. 2010 Feb;36(1):83-90. doi: 10.1016/j.ctrv.2009.10.008. Epub 2009 Nov 26.
Results Reference
background
PubMed Identifier
15501119
Citation
Lawrence VA, Hazuda HP, Cornell JE, Pederson T, Bradshaw PT, Mulrow CD, Page CP. Functional independence after major abdominal surgery in the elderly. J Am Coll Surg. 2004 Nov;199(5):762-72. doi: 10.1016/j.jamcollsurg.2004.05.280.
Results Reference
background
PubMed Identifier
20573634
Citation
Wilson RJ, Davies S, Yates D, Redman J, Stone M. Impaired functional capacity is associated with all-cause mortality after major elective intra-abdominal surgery. Br J Anaesth. 2010 Sep;105(3):297-303. doi: 10.1093/bja/aeq128. Epub 2010 Jun 23.
Results Reference
background
PubMed Identifier
23880071
Citation
Robinson TN, Wu DS, Pointer L, Dunn CL, Cleveland JC Jr, Moss M. Simple frailty score predicts postoperative complications across surgical specialties. Am J Surg. 2013 Oct;206(4):544-50. doi: 10.1016/j.amjsurg.2013.03.012. Epub 2013 Jul 20.
Results Reference
background
PubMed Identifier
26483875
Citation
Millan M, Merino S, Caro A, Feliu F, Escuder J, Francesch T. Treatment of colorectal cancer in the elderly. World J Gastrointest Oncol. 2015 Oct 15;7(10):204-20. doi: 10.4251/wjgo.v7.i10.204.
Results Reference
background
PubMed Identifier
25403592
Citation
Handforth C, Clegg A, Young C, Simpkins S, Seymour MT, Selby PJ, Young J. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015 Jun;26(6):1091-1101. doi: 10.1093/annonc/mdu540. Epub 2014 Nov 17.
Results Reference
background
PubMed Identifier
24672230
Citation
Chen X, Mao G, Leng SX. Frailty syndrome: an overview. Clin Interv Aging. 2014 Mar 19;9:433-41. doi: 10.2147/CIA.S45300. eCollection 2014.
Results Reference
background
PubMed Identifier
11253156
Citation
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56. doi: 10.1093/gerona/56.3.m146.
Results Reference
background
PubMed Identifier
27338516
Citation
Fagard K, Leonard S, Deschodt M, Devriendt E, Wolthuis A, Prenen H, Flamaing J, Milisen K, Wildiers H, Kenis C. The impact of frailty on postoperative outcomes in individuals aged 65 and over undergoing elective surgery for colorectal cancer: A systematic review. J Geriatr Oncol. 2016 Nov;7(6):479-491. doi: 10.1016/j.jgo.2016.06.001. Epub 2016 Jun 21.
Results Reference
background
PubMed Identifier
24440732
Citation
Debes C, Aissou M, Beaussier M. [Prehabilitation. Preparing patients for surgery to improve functional recovery and reduce postoperative morbidity]. Ann Fr Anesth Reanim. 2014 Jan;33(1):33-40. doi: 10.1016/j.annfar.2013.12.012. Epub 2014 Jan 17. French.
Results Reference
background
PubMed Identifier
35588252
Citation
Molenaar CJ, van Rooijen SJ, Fokkenrood HJ, Roumen RM, Janssen L, Slooter GD. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery. Cochrane Database Syst Rev. 2022 May 19;5(5):CD013259. doi: 10.1002/14651858.CD013259.pub2.
Results Reference
derived

Learn more about this trial

Prehabilitation in Frail Colon Cancer

We'll reach out to this number within 24 hrs